Clinical Trial Update: Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating omitting breast surgery in breast cancer patients who achieve clinical complete response after neoadjuvant systemic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING